Evaluating risk of bullous pemphigoid after mRNA COVID‐19 vaccination
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:187 |
---|---|
Enthalten in: |
British Journal of Dermatology - 187(2022), 2, Seite 271-273 |
Beteiligte Personen: |
Birabaharan, Morgan [VerfasserIn] |
---|
BKL: |
---|
Anmerkungen: |
Copyright © 2022 British Association of Dermatologists |
---|
Umfang: |
273 |
---|
doi: |
10.1111/bjd.21240 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
WLY002785315 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | WLY002785315 | ||
003 | DE-627 | ||
005 | 20230307121936.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230213s2022 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1111/bjd.21240 |2 doi | |
028 | 5 | 2 | |a BJD_BJD21240.xml |
035 | |a (DE-627)WLY002785315 | ||
035 | |a (WILEY)BJD21240 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.93 |2 bkl | ||
100 | 1 | |a Birabaharan, Morgan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Evaluating risk of bullous pemphigoid after mRNA COVID‐19 vaccination |
264 | 1 | |c 2022 | |
300 | |a 273 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Copyright © 2022 British Association of Dermatologists | ||
700 | 1 | |a Kaelber, David C. |4 aut | |
700 | 1 | |a Orme, Charisse M. |4 aut | |
700 | 1 | |a Paravar, Taraneh |4 aut | |
700 | 1 | |a Karris, Maile Y. |4 aut | |
773 | 0 | 8 | |i Enthalten in |t British Journal of Dermatology |g 187(2022), 2, Seite 271-273 |w (DE-627)WLY002735717 |x 13652133 |7 nnns |
773 | 1 | 8 | |g volume:187 |g year:2022 |g number:2 |g pages:271-273 |g extent:273 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_WLY | ||
936 | b | k | |a 44.93 |q ASE |
951 | |a AR | ||
952 | |d 187 |j 2022 |e 2 |h 271-273 |g 273 |